Literature DB >> 12955444

[Relevant allergans by periorbital allergic contact dermatitis. Oxybuprocain, an underestimated allergen].

V Blaschke1, T Fuchs.   

Abstract

BACKGROUND: Periorbital allergic contact dermatitis is a rare disease and the main differential diagnoses are atopic and seborrhoeic dermatitis. The diagnosis is based on clinical appearance, patient history and patch testing. Current systematic overviews on contact allergens involved are lacking and with changes in medical preparations, new relevant antigens may emerge. PATIENTS AND METHODS: Based on the systematic data of the information network of dermatological clinics (IVDK), patch test reactions in 48,969 patients tested between 1996 and 2000 were evaluated. A total of 763 patients suffered from periorbital dermatitis which was suspected to be due to the use of topical medication.
RESULTS: The most common epidermal sensitizations in the general population were observed against nickel and fragrances. In the periorbital dermatitis group, sensitization against local anaesthetics and antibiotics was more frequent than in the general population.
CONCLUSIONS: In three patients, oxybuprocain was identified as the causative agent, which has not yet been recognized as a common allergen.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12955444     DOI: 10.1007/s00347-002-0754-2

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  14 in total

1.  Contact sensitivity to multiple local anesthetics.

Authors:  D C Redfern
Journal:  J Allergy Clin Immunol       Date:  1999-10       Impact factor: 10.793

2.  Contact allergy to 'caines' caused by anti-hemorrhoidal ointments.

Authors:  A Lodi; M Ambonati; A Coassini; Z Kouhdari; M Palvarini; C Crosti
Journal:  Contact Dermatitis       Date:  1999-10       Impact factor: 6.600

3.  Immunological investigations following an adverse reaction to oxybuprocaine eye drops.

Authors:  W A Sewell; J J Croucher; A G Bird
Journal:  Br J Ophthalmol       Date:  1999-05       Impact factor: 4.638

4.  Contact allergy in patients with periorbital eczema: an analysis of allergens. Data recorded by the Information Network of the Departments of Dermatology.

Authors:  H M Ockenfels; U Seemann; M Goos
Journal:  Dermatology       Date:  1997       Impact factor: 5.366

5.  Bradycardia as a side-effect to oxybuprocaine.

Authors:  C Christensen
Journal:  Acta Anaesthesiol Scand       Date:  1990-02       Impact factor: 2.105

Review 6.  Allergic contact dermatitis from lignocaine: report of 29 cases and review of the literature.

Authors:  W Weightman; T Turner
Journal:  Contact Dermatitis       Date:  1998-11       Impact factor: 6.600

7.  Oxybuprocaine keratopathy: a preventable disease.

Authors:  E P Penna; K F Tabbara
Journal:  Br J Ophthalmol       Date:  1986-03       Impact factor: 4.638

8.  Benzocaine--an unsatisfactory indicator of topical local anaesthetic sensitization for the U.K.

Authors:  M H Beck; A Holden
Journal:  Br J Dermatol       Date:  1988-01       Impact factor: 9.302

9.  [Benzalkonium chloride--a relevant contact allergen or irritant? Results of a multicenter study of the German Contact Allergy Group].

Authors:  T Fuchs; A Meinert; W Aberer; F A Bahmer; K P Peters; G G Lischka; A Schulze-Dirks; F Enders; P J Frosch
Journal:  Hautarzt       Date:  1993-11       Impact factor: 0.751

10.  Fibrinous iritis due to oxybuprocaine.

Authors:  R Haddad
Journal:  Br J Ophthalmol       Date:  1989-01       Impact factor: 4.638

View more
  1 in total

1.  [Classification of biomedical research reports as a reference for evidence-based medicine in ophthalmology. A survey considering as example the journal Der Ophthalmologe].

Authors:  H P N Scholl; M Fleckenstein; T U Krohne; F G Holz
Journal:  Ophthalmologe       Date:  2005-12       Impact factor: 1.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.